S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
Log in

ASX:COH - Cochlear Stock Price, Forecast & News

A$207.59
-1.26 (-0.60 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
A$203.05
Now: A$207.59
A$209.65
50-Day Range
A$208.85
MA: A$235.75
A$247.90
52-Week Range
A$164.00
Now: A$207.59
A$251.55
Volume394,920 shs
Average Volume194,422 shs
Market Capitalization$12.00 billion
P/E Ratio39.21
Dividend Yield1.38%
BetaN/A
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. Read More…

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-94286555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash FlowA$1.36 per share
Book ValueA$13.95 per share

Profitability

Miscellaneous

Employees3,500
Market Cap$12.00 billion
Next Earnings DateN/A
OptionableOptionable

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter.


Cochlear (ASX:COH) Frequently Asked Questions

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a Interim dividend on Wednesday, February 19th. Shareholders of record on Friday, April 17th will be given a dividend of 1.60 per share on Friday, April 17th. This represents a yield of 0.64%. The ex-dividend date is Tuesday, March 24th. This is a boost from Cochlear's previous Interim dividend of $1.55. View Cochlear's Dividend History.

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) issued its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.19 by $0.04. View Cochlear's Earnings History.

Has Cochlear been receiving favorable news coverage?

News stories about COH stock have trended somewhat positive on Friday, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cochlear earned a news impact score of 1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Cochlear.

Who are some of Cochlear's key competitors?

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), ResMed (RMD), Alumina (AWC), CSL (CSL), Nufarm (NUF), REA Group (REA), TPG Telecom (TPM), Janus Henderson Group (HGG), Mesoblast (MESO) and Omnicell (OMCL).

Who are Cochlear's key executives?

Cochlear's management team includes the folowing people:
  • Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)
  • Mr. Brent Andrew Cubis, Chief Financial Officer
  • Mr. Jan Janssen, Chief Technology Officer
  • Mr. Richard Brook, Pres of EMEA & Latin American Region
  • Mr. Anthony Manna, Pres of Americas Region

What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately A$207.59.

How big of a company is Cochlear?

Cochlear has a market capitalization of $12.00 billion and generates $1.48 billion in revenue each year. Cochlear employs 3,500 workers across the globe.View Additional Information About Cochlear.

What is Cochlear's official website?

The official website for Cochlear is http://www.cochlear.com/.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.


MarketBeat Community Rating for Cochlear (ASX COH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  158 (Vote Outperform)
Underperform Votes:  245 (Vote Underperform)
Total Votes:  403
MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe COH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: S&P/TSX Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel